alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Independent Auditors' Report


To the Shareholders and Board of Trustees of
Smith Barney Investment Series:

In planning and performing our audits of the financial statements of
the Smith Barney Investment Series (the Funds) consisting of Smith
Barney Large Cap Core Portfolio, Smith Barney Premier Selections All
Cap Growth Portfolio, Smith Barney Growth and Income Portfolio, and
Smith Barney Government Portfolio for the year ended October 31,
2001, we considered its internal control, including control
activities for safeguarding securities, in order to determine our
auditing procedures for the purpose of expressing our opinion on the
financial statements and to comply with the requirements of Form N-
SAR, not to provide assurance on the internal control.

The management of the Funds is responsible for establishing and
maintaining internal control.  In fulfilling this responsibility,
estimates and judgments by management are required to assess the
expected benefits and related costs of controls.  Generally, controls
that are relevant to an audit pertain to the entity's objective of
preparing financial statements for external purposes that are fairly
presented in conformity with accounting principles generally accepted
in the United States of America. Those controls include the
safeguarding of assets against unauthorized acquisition, use, or
disposition.

Because of inherent limitations in internal control, error or fraud
may occur and not be detected.  Also, projection of any evaluation of
internal control to future periods is subject to the risk that it may
become inadequate because of changes in conditions or that the
effectiveness of the design and operation may deteriorate.

Our consideration of the internal control would not necessarily
disclose all matters in the internal control that might be material
weaknesses under standards established by the American Institute of
Certified Public Accountants.  A material weakness is a condition in
which the design or operation of one or more of the internal control
components does not reduce to a relatively low level the risk that
misstatements caused by error or fraud in amounts that would be
material in relation to the financial statements being audited may
occur and not be detected within a timely period by employees in the
normal course of performing their assigned functions.  However, we
noted no matters involving the internal control and its operation,
including controls for safeguarding securities that we consider to be
material weaknesses as defined above as of October 31, 2001.

This report is intended solely for the information and use of
management, the Board of Trustees of the Funds, and the Securities
and Exchange Commission and is not intended to be and should not be
used by anyone other than these specified parties.


New York, New York
December 12, 2001
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4865 Introduced in House (IH)]

110th CONGRESS
  1st Session
                                H. R. 4865

To extend the temporary suspension of duty on p-Cresidinesulfonic acid 
           (4-amino-5-methoxy-2-methylbenzenesulfonic acid).

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 19, 2007

   Mr. Clay introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
To extend the temporary suspension of duty on p-Cresidinesulfonic acid 
           (4-amino-5-methoxy-2-methylbenzenesulfonic acid).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. P-CRESIDINESULFONIC ACID (4-AMINO-5-METHOXY-2-
              METHYLBENZENESULFONIC ACID).

    (a) In General.--Heading 9902.01.65 of the Harmonized Tariff 
Schedule of the United States is amended by striking ``12/31/2009'' and 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1473 Introduced in House (IH)]

113th CONGRESS
  1st Session
                                H. R. 1473

 To prevent certain Federal health care laws from establishing health 
 care provider standards of care in medical malpractice cases, and for 
                            other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 10, 2013

  Mr. Gingrey of Georgia (for himself and Mr. Cuellar) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on the Judiciary, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
 To prevent certain Federal health care laws from establishing health 
 care provider standards of care in medical malpractice cases, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Standard of Care Protection Act of 
2013''.

SEC. 2. CONSTRUCTION REGARDING HEALTH CARE PROVIDER STANDARDS OF CARE.

    (a) In General.--The development, recognition, or implementation of 
any guideline or other standard under any Federal health care provision 
shall not be construed to establish the standard of care or duty of 
care owed by a health care provider to a patient in any medical 
malpractice case.
    (b) Definitions.--For purposes of this Act:
            (1) The term ``Federal health care provision'' means any 
        provision of the Patient Protection and Affordable Care Act 
        (Public Law 111-148) and the amendments made by that Act, and 
        titles XVIII and XIX of the Social Security Act.
            (2) The term ``medical malpractice case'' means a medical 
        malpractice action or claim (as defined in section 431(7) of 
        the Health Care Quality Improvement Act of 1986 (42 U.S.C. 
        11151(7))).
            (3) The term ``State'' includes the District of Columbia, 
        Puerto Rico, and any other commonwealth, possession, or 
        territory of the United States.
    (c) No Preemption.--No provision of the Patient Protection and 
Affordable Care Act (Public Law 111-148) or the amendments made by that 
Act shall be construed to preempt any State law governing medical 
professional liability cases.
                                 <all>
```
Jess Lee GREEN, Petitioner v. MISSISSIPPI

No. 19-6717

Supreme Court of the United States.

January 13, 2020

*877Petition for writ of certiorari to the Court of Appeals of Mississippi denied.
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Physicians Formula Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2010, as filed with the Securities and Exchange Commission (the “Report”), I, Ingrid Jackel, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.





Date: August 6, 2010





By:
/s/ Ingrid JackelName:
Ingrid JackelTitle:
Chief Executive Officer








A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Physicians Formula Holdings, Inc. and will be retained by Physicians Formula Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
STATE v. SMITH

No. COA04-232

North Carolina Court of Appeals

Filed October 19, 2004

Certification Date November 8, 2004

Case reported without published opinion. Affirmed.
STATE v. Jathiyah AL-BAYYINAH.

No. 550A03.

Supreme Court of North Carolina.

October 18, 2004.

William P. Hart, Special Deputy Attorney General, Garry W. Frank, District Attorney, for State.

Janet Moore, Assistant Public Defender, Joan Cunningham, Assistant Attorney General, for Jathiyah al-Bayyinah.

The following order has been entered on the motion filed on the 18th day of October 2004 by Defendant for Extension of Time to File Brief:

> "Motion Allowed. Defendant (Jathiyah al-Bayyinah) shall have up to and including the 16th day of December 2004 to file and serve his/her brief with this Court. By order of the Court in conference this the 18th day of October 2004."
Exhibit 32.1


CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officer of Blackstone / GSO Secured Lending Fund (the “Company”), does hereby certify that to the undersigned’s knowledge:


(1) the Company’s Form 10-K for the year ended December 31, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) the information contained in the Company’s Form 10-K for the year ended December 31, 2019 fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: February 27, 2020


By:/s/ Brad MarshallBrad MarshallChief Executive Officer
exv10w3



 



Exhibit 10.3


SECOND AMENDMENT TO LICENSE & DEVELOPMENT AGREEMENT



          This Amendment, dated July 15, 2003, (“Second Amendment”) is the Second
Amendment to that certain License and Development Agreement dated April 24,
2002 (“Agreement”) between SIERRA DESIGN GROUP, a Nevada corporation with
offices at 300 Sierra Manor Drive, Reno, NV 89511 (“LICENSOR”) and WMS Gaming
Inc., a Delaware corporations with offices at 800 S. Northpoint Boulevard,
Waukegan, IL 60085 (“LICENSEE”), and as amended on June 12, 2003 (“First
Amendment”).



          WHEREAS, the parties desire to amend the Agreement;



          THEREFORE, in consideration of the terms and conditions and the covenants
set forth in this Amendment, the sufficiency and receipt of which is hereby
acknowledged, LICENSOR and LICENSEE agree as follows:




	1.	 	The following is inserted in its entirety to the end of Section 4d within
this section of the Agreement, as amended: “LICENSOR and LICENSEE agree
that the development and QA process will require LICENSOR’s access to
LICENSEE’s confidential BluebirdTM cabinet design (“Bluebird”). As such,
during the development and QA process, LICENSOR agrees that LICENSOR shall
not make any modifications or corrections to Bluebird hardware without (i)
prior notification to an authorized employee of LICENSEE, and (ii) an
authorized employee of LICENSEE present who shall be available within four
business hours from SDG’s request thereof. LICENSEE shall also seal such
confidential areas of Bluebird in a manner which shall prevent LICENSOR
from learning of the confidential nature of Bluebird. LICENSEE shall
provide access to Bluebird only to those LICENSOR employees who are
reasonably required to have such access in connection with this Agreement
and only to the extent necessary to perform the development and QA process
hereunder. Notwithstanding the foregoing, LICENSOR further agrees that,
in the event LICENSOR learns of the confidential nature of Bluebird,
LICENSOR agrees to maintain the confidentiality of such information on the
terms set forth in Section 11 herein.”
	 
	2.	 	Except as specifically modified or amended by the Second Amendment, all
of the terms and conditions of the Agreement and First Amendment are
unmodified and shall remain in full force and effect. In the event a
discrepancy arises between the terms and conditions of the Agreement,
First Amendment and the Second Amendment, this Second Amendment shall
prevail.



IN WITNESS WHEREOF, the parties hereto have signed this Agreement as of the day
and year first above written.



	 	 	 	 	 	 	 
	SIERRA DESIGN GROUP	 	WMS GAMING INC.
	 	 	 	 	 	 	 
	By:	 	
 /s/ Robert A. Luciano, Jr.
	 	By:
	 	 /s/ Brian R. Gamache
	 	 	


	 	 	 	

	Title: President	 	Title: President and CEO



1
Exhibit
35.1







Servicer
Compliance Statement of AmeriCredit Financial Services, Inc.



This
Annual Statement as to Compliance is delivered to you pursuant to Section 2.9 (c) of the 2018-1 Servicing Supplement dated as
of December 25, 2017 (the “Agreement”) and Item 1123 of Regulation AB, executed in connection with the formation of
GM Financial Automobile Leasing Trust 2018-1 (the “Trust”), the issuance of the Notes by the Trust and the closing
of the transactions and the execution and delivery of the various documents by AmeriCredit Financial Services, Inc. (the “Servicer”)
and GMF Leasing LLC in connection therewith. The capitalized terms used herein shall have the same meanings as in the Agreement.



The
undersigned certifies that I am the Executive Vice President, Corporate Controller and Chief Accounting Officer of the Servicer.
I further certify as follows:



| | 1. | I
                                         have conducted, or caused to be conducted under my supervision, a review of the Servicer
                                         during the preceding period from January 1, 2018 through December 31, 2018, and its performance
                                         under the Agreement.
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To
                                         the best of my knowledge, following such review, the Servicer has fulfilled all its obligations
                                         under the Agreement throughout such period, and, to the best of my knowledge, there has
                                         been no default in the fulfillment of any such obligation.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------





|                                         |                                             |  |                     
|---------------------------------------- | ------------------------------------------- |  | --------------------
|AmeriCredit Financial
    Services, Inc. |                                             | 
|                                         |                                             |  |                     
|By:                                      | /s/
    Connie Coffey                       |  | Dated: March 8, 2019
|                                         | Connie Coffey                               |  |                     
|                                         | Executive Vice President, Corporate         |  |                     
|                                         | Controller and Chief Accounting
    Officer |  |
Ronald Wayne JOYCE v. STATE of North Carolina.

No. 376P04.

Supreme Court of North Carolina.

August 12, 2004.

Ronald Wayne Joyce, Pro Se.

William P. Hart, Special Deputy Attorney General, R. Stuart Albright, District Attorney, for State of NC.

***ORDER***

Upon consideration of the petition filed by Defendant on the 26th day of July 2004 in this matter for a writ of certiorari to review the order of the North Carolina Court of Appeals, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

> "Dismissed by order of the Court in conference, this the 12th day of August 2004."
SMITH BARNEY MONEY FUNDS, INC.
(the "Fund")

Supplement to Prospectus dated February 16, 1996



In order to provide the Investment Manager with additional investment 
flexibility, The Fund's Board of Directors approved the following supplemental 
changes to the Fund's investment policies by amending the Section of the 
Prospectus entitled "Investment Objectives and Policies-Bank Obligations" as 
follows:

(1) the previously authorized investment in time deposits is expanded to 
permit the Fund to invest in term time deposits with an ultimate maturity of 
six months and; 

(2) the list of foreign bank branches through which the Fund may invest in 
fixed time deposits of foreign banks is expanded to include London branches of 
foreign banksq.













Supplement dated : December 18, 1996

FD________
I 

110TH CONGRESS 

1ST SESSION H. R. 4868 

To extend the temporary suspension of duty on Basic Yellow 40 chloride 

based. 

IN THE HOUSE OF REPRESENTATIVES 

DECEMBER 19, 2007 

Mr. CLAY introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To extend the temporary suspension of duty on Basic Yellow 

40 chloride based. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. BASIC YELLOW 40 CHLORIDE BASED. 

4 (a) IN GENERAL.—Heading 9902.25.04 of the Har5 monized Tariff Schedule of the United States is amended 

6 by striking ‘‘12/31/2009’’ and inserting ‘‘12/31/2011’’. 

7 (b) EFFECTIVE DATE.—The amendment made by 

8 subsection (a) applies with respect to goods entered, or 


bajohnson on PROD1PC69 with BILLS
2 

•HR 4868 IH

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


bajohnson on PROD1PC69 with BILLS
Franklin Elliott BENSON, Petitioner, v. Aimee SMITH, Warden.

No. 19-6524

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Exhibit 32.2



CERTIFICATION



I, Alan Campbell, Senior Vice President and Chief Financial Officer of Freescale Semiconductor, Inc., certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge:



|(1) | the quarterly report on Form 10-Q for the quarterly period ended April 1, 2005 (the Quarterly Report), which this statement accompanies fully complies with the
requirements of Section 13(a) for the Securities Exchange Act of 1934 (15 U.S.C. 78m) and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) | information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Freescale Semiconductor, Inc.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------



This certificate is being furnished solely for purposes of
Section 906.



Dated: May 2, 2005



/s/ Alan CampbellAlan CampbellSenior Vice President and Chief Financial Officer, Freescale Semiconductor, Inc.




32
Exhibit 31.2



CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE
SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Felix Wong, certify that:



| | 1. | I have reviewed this Annual Report on Form 10-K/A of Tottenham Acquisition I Limited;                                                                                                                                                                                                                     
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                                                                                                                                                                           
| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
| |    |                                                                                                                                                                                                                                                                                                           
| |    | Date: September 4, 2020                                                                                                                                                                                                                                                                                   





| | /s/ Felix Wong                              
| | --------------------------------------------
| | Felix Wong                                  
| | Chief Financial Officer                     
| | (Principal financial and accounting officer)
EXHIBIT
32.1




CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER


PURSUANT
TO 18 U.S.C. § 1350





(SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002)





I, Song
Jinan, Chief Executive Officer (principal executive officer) of China-Biotics,
Inc. (the "Registrant"), certify pursuant to 18 U.S.C. § 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based upon a
review of the Quarterly Report on Form 10-Q for the period ended December 31,
2008 of the Registrant (the “Report”):





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of The
Securities Exchange Act of 1934, as amended; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.





A signed
original of this written statement required by Section 906 has been provided to
the Registrant and will be retained by the Registrant and furnished to the
Securities and Exchange Commission or its staff upon request.




/s/
      Song JinanSong
      JinanChief
      Executive OfficerFebruary
      13,
2009